Amsbio recently announced a new distribution partnership with arcoris bio to supply immunoMUSE kits across North America and Europe. This multiplex immunofluorescence platform enables researchers to design custom panels using their preferred antibodies while minimizing workflow bottlenecks. By utilizing a proprietary nanotechnology signal amplification system, the kits replace complex cyclical staining protocols with a two-step process that accelerates biomarker detection for spatial biology applications.

Editor's Note: Supply chain reliability and vendor accessibility serve as critical factors for lab managers adopting new spatial biology platforms. This distribution agreement highlights an industry trend toward collaborative partnerships that reduce procurement bottlenecks and ensure consistent reagent access for biomarker research.

How does the immunoMUSE platform improve workflow efficiency?

The platform improves workflow efficiency by replacing traditional cyclical staining with a simultaneous, room-temperature protocol. This shift reduces the hands-on time required from laboratory technicians and minimizes the risk of tissue degradation associated with chemical stripping. Consequently, laboratories process higher sample volumes without compromising the structural integrity of delicate specimens.

Conventional multiplex immunofluorescence often relies heavily on sequential cycles of staining and stripping. Foundational methodological studies demonstrate that these repetitive cycles degrade delicate tissue samples and extend protocol timelines across multiple days. By eliminating overnight incubation steps for cyclic antigen retrieval, labs condense their protocol timelines.

The immunoMUSE system bypasses these limitations by operating entirely at room temperature without requiring cyclic antigen removal. The technology utilizes a two-step process powered by proprietary MUSE signal amplification technology. Laboratory technicians process digital pathology samples faster and achieve same-day results while maintaining tissue context.

The immunoMUSE platform enhances assay sensitivity across research applications

The system enhances assay sensitivity by replacing enzyme-based amplification with a nanotechnology signal system that reduces background interference and non-specific binding. This enhanced sensitivity allows researchers to leverage existing validated antibodies while achieving better signal-to-noise ratios for low-abundance targets. Consequently, scientists extract biological insights from single samples, making it a functional tool for complex spatial analysis.

"[With immunoMUSE®], we put control over multiplex panel design directly into the hands of researchers," said Simon Restrepo, chief scientific officer at arcoris bio. The platform's flexibility allows research teams to adapt their existing antibody libraries to higher-order multiplexing without extensive re-optimization. Furthermore, maintaining spatial integrity while boosting target signals remains critical for labs investigating heterogeneous tissue microenvironments.

Lab Quality Management Certificate

The Lab Quality Management certificate is more than training—it’s a professional advantage.

Gain critical skills and IACET-approved CEUs that make a measurable difference.

The platform addresses core operational challenges across several life science disciplines. Key application areas include:

• Oncology: profiling tumor microenvironments and identifying rare or low-abundance biomarkers.
• Neurobiology: studying complex neuronal networks and subtle protein expression patterns.
• Immunology: characterizing immune cell populations and their biological interactions.
• Spatial biology: performing multiplex immunofluorescence while preserving spatial context within tissues.

Consolidating regional supply chains reduces spatial biology assay costs

Expanded access through Amsbio reduces spatial biology assay costs by minimizing procurement complexities and hidden shipping fees for North American and European laboratories. Because financial and temporal costs dictate when lab managers evaluate new assays, this consolidated reagent sourcing provides a stable budgetary outlook. Simplifying the supply chain allows labs to scale their spatial biology experiments without encountering the vendor bottlenecks associated with specialized reagents.

Traditional cyclical approaches demand substantial consumable budgets, which significantly impact overall assay expenses. Because Amsbio directly distributes these automation-friendly kits, regional laboratories avoid international shipping delays and streamline their purchasing workflows. This direct distribution model provides regional facilities with reduced downtime and greater operational consistency.

Evaluating and scaling new spatial technologies requires lab managers to carefully balance upfront instrument costs against ongoing consumable expenses. The distributed product portfolio includes two primary kit variations, available in small, medium, and large specifications, to accommodate different throughput needs. The Activate and Amplify kits prepare user antibodies, while standalone Amplify kits supply additional amplification reagents for established panels.

Amsbio partnership advances regional access to biomarker detection

The distribution agreement between Amsbio and arcoris bio provides lab managers with an accessible method for multiplex immunofluorescence. By streamlining the supply chain and replacing traditional sequential staining with rapid signal amplification, the platform offers a practical solution for high-throughput biomarker detection. This expanded distribution network ensures that North American and European laboratories can quickly integrate these tools to maintain operational efficiency.

This content includes text that has been generated with the assistance of AI. For more information, view Lab Manager's AI use policy.